• Explore /
  • Poster
  • / Sequential treatment with Nab-paclitaxel plus Gemcitabine and Folfirinox in metastatic pancreatic adenocarcinoma: GABRINOX phase II results.

Sequential treatment with Nab-paclitaxel plus Gemcitabine and Folfirinox in metastatic pancreatic adenocarcinoma: GABRINOX phase II results.

Abstract Poster

Authors

null

Eric Assenat

Institut du Cancer de Montpellier (ICM), Univ Montpellier, Montpellier, France

Eric Assenat , Christelle De La Fouchardiere , Caroline Mollevi , Emmanuelle Samalin , Fabienne Portales , Françoise Desseigne , Christophe Carenco , Marie Dupuy , Ernesto Lopez-Martinez , Catherine Fiess , Thibault Mazard , Marc Ychou

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2018 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal (Noncolorectal) Cancer

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Pancreatic Cancer

Clinical Trial Registration Number

NCT01964287

Citation

J Clin Oncol 36, 2018 (suppl; abstr 4109)

DOI

10.1200/JCO.2018.36.15_suppl.4109

Abstract #

4109

Poster Bd #

298

Abstract Disclosures

Similar Posters

First Author: Angela Tatiana Alistar

Poster

2024 ASCO Gastrointestinal Cancers Symposium

A phase I/II study of antroquinonol in combination with nab-paclitaxel and gemcitabine for patients with metastatic pancreatic cancer.

A phase I/II study of antroquinonol in combination with nab-paclitaxel and gemcitabine for patients with metastatic pancreatic cancer.

First Author: Yan-Shen Shan

First Author: Jaime Feliu Batlle

First Author: Angela Tatiana Alistar